Insider: Gollob Jared Chief Medical Officer - Kymera Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 120,000 | 0 | 120,000 |
| Value | $6,607,200.00 | $0.00 | $6,607,200.00 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/03/2025 | DDS | 1,045 | Direct | COM | $31.00 | $32,399.81 | 120,000 |
| 03/03/2025 | DDS | 4,695 | Direct | COM | $30.33 | $142,385.73 | 121,045 |
| 07/16/2024 | DDS | 13,281 | Direct | COM | $45.59 | $605,521.96 | 105,604 |
| 07/16/2024 | DDS | 9,864 | Direct | COM | $46.10 | $454,695.88 | 95,470 |
| 07/15/2024 | DDS | 16,455 | Direct | COM | $45.15 | $742,925.15 | 95,740 |
| 03/04/2024 | DDS | 2,022 | Direct | COM | $41.41 | $83,738.10 | 97,062 |
| 03/04/2024 | DDS | 1,106 | Direct | COM | $42.39 | $46,885.99 | 95,956 |
| 03/04/2024 | DDS | 216 | Direct | COM | $43.26 | $9,343.38 | 95,740 |
| 02/27/2024 | DDS | 400 | Direct | COM | $45.00 | $18,000.00 | 74,709 |
| 02/09/2024 | DDS | 38,739 | Direct | COM | $35.39 | $1,371,058.44 | 82,107 |
| 02/09/2024 | DDS | 7,398 | Direct | COM | $36.09 | $267,013.05 | 74,709 |
| 03/02/2023 | DDS | 1,001 | Direct | COM | $30.88 | $30,908.28 | 75,006 |
| 03/02/2023 | DDS | 297 | Direct | COM | $31.40 | $9,325.00 | 74,709 |
| 11/02/2021 | DDS | 8,514 | Direct | COM | $62.89 | $535,442.05 | 31,139 |
| 11/02/2021 | DDS | 1,202 | Direct | COM | $64.34 | $77,333.19 | 24,657 |
| 11/02/2021 | DDS | 5,280 | Direct | COM | $63.50 | $335,287.39 | 25,859 |
| 11/01/2021 | DDS | 7,387 | Direct | COM | $60.40 | $446,141.56 | 59,767 |
| 11/01/2021 | DDS | 15,134 | Direct | COM | $61.50 | $930,709.22 | 44,633 |
| 11/01/2021 | DDS | 15,911 | Direct | COM | $62.34 | $991,945.84 | 28,722 |
| 11/01/2021 | DDS | 4,065 | Direct | COM | $63.17 | $256,798.65 | 24,657 |
| 03/15/2021 | DDS | 10,305 | Direct | COM | $60.17 | $620,051.85 | 42,547 |
| 03/11/2021 | DDS | 4,695 | Direct | COM | $60.05 | $281,938.98 | 45,052 |
| 02/24/2021 | DDS | 8,675 | Direct | COM | $50.91 | $441,671.14 | 47,547 |
| 02/23/2021 | DDS | 19,285 | Direct | COM | $49.65 | $957,554.25 | 56,222 |
| 02/22/2021 | DDS | 9,104 | Direct | COM | $52.63 | $479,129.86 | 75,507 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research